
Michael Frumovitz
@frumovitz
ID: 500124733
22-02-2012 20:39:47
106 Tweet
1,1K Followers
53 Following

Our lab at MD Anderson Cancer Center draws blood from > 15,000 patients/week and always provides outstanding #serviceexcellence to every single one of our cancer patients. Congratulations for their outstanding patient scores for #patientexperience. Beth Comcowich Garcia


Excited to announce our clinical trial with surgery and #HIPEC for recurrent mucinous ovarian cancer is now open at MD Anderson Cancer Center. Will also open at MSKCC later this year with our colleagues Oliver Zivanovic and Jenny Mueller MD. Shelley LM Katie Kurnit Anil Sood



Our trial with immunotherapy AK104 (cadonilimab) for women with neuroendocrine cervix cancer at MD Anderson Cancer Center opened just this week! We already have 1 enrolled and 2 in screening. Trials for #raretumors are possible! SGO NANETS SCCC/LCCC Sisterhood Shannon Westin, MD, MPH, FASCO Karen Lu


Excited to share a new research award for mucinous ovarian cancer! Application now open, deadline on 6/2. Canโt wait to make some much needed progress for this #raretumor Shelley LM Michael Frumovitz Jenny Mueller MD hope4moc.org/researching/


The deadline to apply for up to $50,000 to fund research on mucinous ovarian cancer is July 14th. Find details about Rhonda's Award here: hope4moc.org/researching/ Michael Frumovitz Jenny Mueller MD Katie Kurnit

The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce Dr. Kylie Gorringe as the recipient of Rhonda's Award. Find all of the details about this annual grant and Dr. Gorringe here: hope4moc.org/mocc-funds-resโฆ Michael Frumovitz Jenny Mueller MD Katie Kurnit

So excited to be at the Allyson Whitney Fnd gala in support of young people with cancer. So appreciative of their amazing support of our #NECC research. MD Anderson Cancer Center SCCC/LCCC Sisterhood


Patient Experience rounds are back MD Anderson Cancer Center with Michael Frumovitz CPXO. Outstanding work going on in Head and Neck Center improving responsiveness and informing about wait times. Their scores reflect their hard work! All domains reached goal this quarter! #ServiceExcellence



โBoth the physical textbook and the ebook achieve this goal and provide guidance from workup to primary treatment to recurrence and surveillance strategies.โ -ยฉDoodyโs Review Service, 2023. Read full review: spkl.io/60174dIgV @frumovitz Mario M. Leitao, Jr Nancy Anastasi Duffy



โThis is likely the most comprehensive book for these rare gynecological cancers.โ -ยฉDoodyโs Review Service, 2023. Read full review: spkl.io/601545B1D @frumovitz, Mario M. Leitao, Jr, Nancy Anastasi Duffy


Honored to receive the Felix Rutledge Society travel award and excited to be presenting my research at this yearโs annual Western Association of Gynecologic Oncologists meeting! I am so grateful for my Hopkins family and amazing mentors ๐ The Hopkins Kelly Gynecologic Oncology Service MD Anderson Cancer Center


Clinicopathologic characteristics, oncologic outcomes & prognostic factors in #neuroendocrine #CervicalCarcinoma #NECTURstudy Anuja Jhingran MD Anderson Cancer Center @frumovitz bit.ly/3tbUAZS Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO OncoAlert


We now have FOUR potential clinical trials open at MD Anderson Cancer Center for patients with small cell/large cell/neuroendocrine cervical cancer. Both targeted and immunotherapies. Excited to offer so many opportunities to patients with this rare cancer SARCC Lauren Averett Byers, MD

The call for proposals is just days away! Mucinous Ovarian Cancer Coalition/MOCC invites researchers to submit abstracts for requests of up to $50,000. Find the full guidelines here: hope4moc.org/researching/ Michael Frumovitz Katie Kurnit Jenny Mueller MD SGO
